GORACCI, ARIANNA
 Distribuzione geografica
Continente #
EU - Europa 10.093
NA - Nord America 8.071
AS - Asia 3.490
SA - Sud America 576
AF - Africa 234
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.497
Nazione #
US - Stati Uniti d'America 7.953
RU - Federazione Russa 3.251
IT - Italia 1.861
GB - Regno Unito 1.784
CN - Cina 1.216
SG - Singapore 1.163
IE - Irlanda 855
SE - Svezia 482
BR - Brasile 476
UA - Ucraina 446
FR - Francia 352
DE - Germania 308
HK - Hong Kong 274
VN - Vietnam 273
PL - Polonia 199
FI - Finlandia 184
ZA - Sudafrica 123
KR - Corea 121
ES - Italia 120
IN - India 112
NL - Olanda 89
JP - Giappone 72
CA - Canada 69
IQ - Iraq 40
TR - Turchia 39
MX - Messico 38
BD - Bangladesh 37
AR - Argentina 36
NG - Nigeria 29
AU - Australia 26
CH - Svizzera 26
PK - Pakistan 22
AT - Austria 20
BE - Belgio 18
IR - Iran 16
MY - Malesia 15
CI - Costa d'Avorio 14
EC - Ecuador 14
CZ - Repubblica Ceca 12
EG - Egitto 12
MA - Marocco 12
GR - Grecia 11
PT - Portogallo 11
SA - Arabia Saudita 11
VE - Venezuela 11
KE - Kenya 10
UY - Uruguay 10
CL - Cile 9
JO - Giordania 9
RO - Romania 9
PH - Filippine 8
UZ - Uzbekistan 8
BG - Bulgaria 7
DK - Danimarca 7
HU - Ungheria 7
ID - Indonesia 7
CO - Colombia 6
PE - Perù 6
TN - Tunisia 6
TW - Taiwan 6
AZ - Azerbaigian 5
DZ - Algeria 5
KZ - Kazakistan 5
PY - Paraguay 5
UG - Uganda 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LU - Lussemburgo 4
NO - Norvegia 4
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
LT - Lituania 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
SI - Slovenia 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
CR - Costa Rica 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
Totale 22.474
Città #
Southend 1.609
Dublin 844
Dallas 781
Ashburn 757
Fairfield 748
Singapore 611
Houston 583
Chandler 470
Santa Clara 388
Moscow 385
Woodbridge 372
Jacksonville 352
Beijing 329
Seattle 286
Wilmington 275
Hong Kong 260
Cambridge 245
San Jose 235
Ann Arbor 208
Hefei 167
Siena 167
Princeton 150
The Dalles 145
Rome 119
Seoul 115
Johannesburg 111
Nanjing 108
Los Angeles 107
Milan 104
Helsinki 99
Málaga 89
Lauterbourg 86
Florence 76
Ho Chi Minh City 71
San Mateo 70
Warsaw 67
Boardman 64
New York 62
Council Bluffs 59
Washington 58
Hanoi 57
Dong Ket 52
Munich 49
Nanchang 43
San Diego 43
Orem 41
São Paulo 39
Tianjin 38
Buffalo 36
Menlo Park 35
Chennai 31
Columbus 30
London 30
Shenyang 30
Abuja 28
Norwalk 28
Brooklyn 27
Naples 25
Bologna 23
Hebei 23
Redondo Beach 23
Dearborn 22
Jiaxing 22
Tokyo 22
Montreal 20
Palermo 20
Prato 20
San Francisco 20
Belo Horizonte 18
Brussels 18
Frankfurt am Main 18
Stockholm 18
Bengaluru 17
Kunming 17
Changsha 16
Jinan 16
Rio de Janeiro 16
Toronto 16
Trento 16
Turku 16
Brescia 15
Catania 15
Chicago 15
Fremont 15
Nuremberg 15
Redwood City 15
Turin 15
Abidjan 14
Da Nang 14
Guangzhou 14
Krakow 14
Mumbai 14
Shanghai 14
Curitiba 13
Zhengzhou 13
Amsterdam 12
Cagliari 12
Latina 12
Manchester 12
Mestre 12
Totale 13.186
Nome #
Questionnaire for the Assessment of Quality of Life in Healthy Subjects (VQV-ss): Elaboration of a new instrument for the assessment of quality of life in the general population [Questionario per la Valutazione della Qualità della Vita nei soggetti sani (VQV-ss): Elaborazione di un nuovo strumento per l'assessment della Qualità della Vita nella popolazione generale] 2.680
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 521
Internet Addiction Disorder in a Sample of 402 High School Students [Zespół uzależnienia od internetu w grupie 402 uczniów szkoły ̈redniej] 454
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 405
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 400
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 355
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 317
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 302
P.5.f.010 Evaluation of the treatment of elderly agitated patients:a preliminary study 283
Mood stabilisers and pregnancy outcomes - a review 281
P.1.k.027 Autoerotic and sexual activity in psychiatric patients 276
P.1.k.034 Psychomotor agitation in emergency medicine settings 275
P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study 262
Liraglutide in psychiatric patients: preliminary results 261
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 259
Drug safety evaluation of aripiprazole in bipolar disorder 258
Personal resources and depression in schizophrenia: the role of self-esteem, resilience and internalized stigma 256
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 256
Le diverse espressioni dell'ansia e della paura: per iniziare a comprendere il mondo di coloro che soffrono di disturbi d'ansia 255
Mood disorders and bariatric surgery: a pilot study 253
Telepsychiatry: new perspectives and open issues 246
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 240
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 237
Early warning symptoms of schizophrenia 237
Advances in treatment for postpartum major depressive disorder 237
Correlazione tra concentrazione plasmatica, efficacia e tollerabilità in un gruppo di pazienti trattati con aripiprazolo. 233
P.8.b.006 Binge eating disorder and bariatric surgery: a pilot study 231
Impulsiveness and psychiatric disorders: a transnosographic comparison among 179 psychiatric inpatients 226
Uno studio pilota sulla concentrazione plasmatica di aripiprazolo. 226
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): A Nationwide Snapshot of the Status of Treatment for Major Depression 222
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 220
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 217
Total aripiprazole dosage: Setting up the method on the cobas® 8000 analyzer [Dosaggio dell’aripiprazolo totale: messa a punto del metodo su analizzatore Cobas 8000] 216
Affective temperaments and subthreshold symptoms spectrum in a clinical sample [Temperamenti affettivi e spettri di psicopatologia sottosoglia in un campione di popolazione clinica] 215
Infertility and psychiatric morbidity 211
Quality of life, anxiety and depression in Sarcoidosis 210
Panic agoraphobic spectrum in psychiatrically healthy subjects: impact on quality of life 208
Possible involvement of opioid systems in obsessive-compulsive disorder: Psychopathological considerations [Possibile coinvolgimento del sistema oppioide nel disturbo ossessivo-compulsivo e relative considerazioni psicopatologiche] 207
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 206
Confini tra disturbo ossessivo-compulsivo e depressione: Considerazioni psicopatologiche 205
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 204
Quality of life and sub threshold affective symptoms 203
Adult obsessive-compulsive disorder and quality of life outcomes: a systematic review and meta-analysis 199
Clinica della mania 198
L' impatto della psicopatologia affettiva (sia conclamata che sottosoglia) sulla qualità della vita 196
Endocrine and metabolic effects of medications used for bipolar disorder [Effetti endocrini e metabolici dei farmaci utilizzati nel disturbo bipolare] 196
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 196
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 194
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 192
Benefici e potenziali rischi dell'utilizzo di antidepressivi in gravidanza: Una revisione della letteratura 188
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 187
Psychopharmacological treatment and personality: Cognitive schemes changes during pharmacological treatments [Psicofarmaci e personalitá: Modificazioni degli schemi cognitivi in corso di trattamenti farmacologici] 186
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 185
Quality of life and subthreshold obsessive-compulsive disorder 184
The effects of undertreated chronic medical illnesses in patients with severe mental disorders 181
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder 181
The asthenia issue in obsessive-compulsive disorder [II problema della astenia nel disturbo ossessivo-compulsivo] 180
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 179
Accuracy of self-assessment of real-life functioning in schizophrenia 179
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 177
The long term-maximising potential for rehabilitation in patients with schizophrenia 177
Trazodone Contramid® in clinical practice: personalizing antidepressant intervention 176
Social phobia spectrum and social phobic behaviours spectrum [Lo spettro della fobia sociale e lo spettro dei comportamenti fobico-sociali] 176
Spettro dell'umore e sindrome metabolica 175
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 174
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 174
Social cognition in people with schizophrenia: a cluster-analytic approach 172
Dimensional nosography of anxiety and mood disorders: The impact on quality of life [Nosografia dimensionale dei disturbi d'ansia e dell'umore: I'impatto sulla qualità di vita] 170
Per una ricerca della nuclearità maniacale al di là delle dimensioni psicopatologiche 170
Pharmacotherapy of binge-eating disorder: a review 168
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives 167
Quetiapine in post-transplant acute mania/bipolar disorder NOS 161
Heterozygosity for Neuronal Ceroid Lipofuscinosis predisposes to Bipolar Disorder 159
Transnosography of aggressiveness, a psychopathological dimension of mania [Aspetti transnosografici dell'aggressività, una delle dimensioni psicopatologiche della mania] 157
null 155
Obsessive-compulsive disorder and quality of life outcomes: Protocol for a systematic review and meta-analysis of cross-sectional case-control studies 154
Psicopatologia della mania: dimensioni fenomenologiche 147
What can we learn from the large US Cohort study (STEP-BD) 147
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 145
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 144
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 143
Relationship of non-suicidal self-injury and suicide attempt: a psychopathological perspective 142
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa 139
Binge eating disorder: from clinical research to clinical practice 135
null 134
Practical guidance for prescribing trazodone extended-release in major depression 132
Physical activity and mental health, psychological and physiological mechanisms 130
Human CRY1 variants associate with attention deficit/hyperactivity disorder 129
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 126
Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression 125
Interazione tra farmaci 121
Quality of life and sensory threshold: Study in a sample of healthy subjects [Qualità della vita e fenomenica sottosoglia: Studio in un campione di soggetti sani] 115
Pharmacokinetic Interactions 113
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 111
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 111
null 106
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 100
null 100
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 98
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 94
Totale 22.516
Categoria #
all - tutte 62.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021613 0 0 0 0 0 0 0 0 0 263 165 185
2021/20221.363 83 140 123 135 97 47 88 101 129 119 71 230
2022/20233.864 98 141 247 239 172 330 62 192 2.119 117 89 58
2023/20241.934 80 55 188 100 140 501 509 64 29 62 80 126
2024/20253.188 97 201 280 259 392 230 118 132 324 140 343 672
2025/20265.631 566 813 546 647 1.270 245 715 234 268 327 0 0
Totale 22.801